Side effects of idelalisib in CLL and how to manage them
Challenges associated with developing treatments for solid and rare tumors
Phase I study shows AG-221 induces durable remissions in IDH2-mutant acute myeloid leukaemia
Precision medicine for MDS, what drugs for which patients?
How to treat difficult forms of MDS